camptothecin has been researched along with hydrazine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Furuta, T; Miyasaka, T; Sawada, S; Yaegashi, T; Yamaguchi, K; Yokokura, T | 1 |
| Adams, DJ; Giles, F; Jacobsen, TF; Myhren, F; Rizzieri, DA; Sandvold, ML | 1 |
| Akama, TO; Bobkov, AA; Fukuda, M; Fukuda, MN; Hatakeyama, S; Nakayama, J; Ohyama, C; Shibata, TK; Sugihara, K; Takano, Y; Tamura, N; Wong, SM | 1 |
| Ojha, U; Patnaik, S; Purohit, MP; Ujjwal, RR | 1 |
| Bhardwaj, U; Gupta, R; Misra, A; Rai, S; Singh, S | 1 |
| Chen, M; Han, B; Liu, B; Zhang, B; Zuo, W | 1 |
6 other study(ies) available for camptothecin and hydrazine
| Article | Year |
|---|---|
Chemical modification of antitumor alkaloids, 20(S)-camptothecin and 7-ethylcamptothecin: reaction of the E-lactone ring portion with hydrazine hydrate.
Topics: Animals; Camptothecin; Female; Hydrazines; Leukemia L1210; Mice | 1993 |
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Cytarabine; Deoxycytidine; Drug Interactions; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Hydrazines; Idarubicin; Irinotecan; Leukemia; Lymphoma; Sulfonamides; Topotecan | 2008 |
Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide.
Topics: Amino Acid Sequence; Animals; Annexin A1; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbohydrates; Cell Line, Tumor; Drug Delivery Systems; HCT116 Cells; Humans; Hydrazines; Injections, Intravenous; Irinotecan; Luminescent Measurements; Mice; Mice, Inbred C57BL; Mice, Nude; Molecular Mimicry; Molecular Sequence Data; Neoplasms; Neovascularization, Pathologic; Peptides; Protein Binding; Xenograft Model Antitumor Assays | 2011 |
General Reagent Free Route to pH Responsive Polyacryloyl Hydrazide Capped Metal Nanogels for Synergistic Anticancer Therapeutics.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Survival; Delayed-Action Preparations; Diffusion; Drug Synergism; Gels; Humans; Hydrazines; Hydrogen-Ion Concentration; Indicators and Reagents; MCF-7 Cells; Metal Nanoparticles; Nanocapsules | 2015 |
Comparison between photostability of Alexa Fluor 448 and Alexa Fluor 647 with conventional dyes FITC and APC by flow cytometry.
Topics: Camptothecin; Carbocyanines; Drug Stability; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Hydrazines; Photochemical Processes | 2018 |
Relationship between CYP2C8, UGT1A1, and ABCG2 gene polymorphisms and the exposure, efficacy, and toxicity of eltrombopag in the treatment of refractory aplastic anemia.
Topics: Anemia, Aplastic; ATP Binding Cassette Transporter, Subfamily G, Member 2; Benzoates; Camptothecin; Cytochrome P-450 CYP2C8; Genotype; Glucuronosyltransferase; Humans; Hydrazines; Neoplasm Proteins; Polymorphism, Genetic; Pyrazoles | 2022 |